Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease—insights and potential therapeutic implications (original) (raw)

• White B (2003) Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 29: 371–390
  Article Google Scholar
• Thannickal VJ et al. (2004) Mechanisms of pulmonary fibrosis. Annu Rev Med 55: 395–417
  Article CAS Google Scholar
• Samuelsson B et al. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171–1176
  Article CAS Google Scholar
• Henderson WR (1994) The role of leukotrienes in inflammation. Ann Intern Med 121: 684–697
  Article CAS Google Scholar
• Serhan CN (2005) Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 73: 141–162
  Article CAS Google Scholar
• Koyama S et al. (1998) Human lung fibroblasts release chemokinetic activity for monocytes constitutively. Am J Physiol 275: L223–L230
  CAS PubMed Google Scholar
• Palmantier R et al. (1991) Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists. Br J Pharmacol 103: 1909–1916
  Article CAS Google Scholar
• Fiore S et al. (1990) Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J Exp Med 172: 1451–1457
  Article CAS Google Scholar
• Schonfeld W et al. (1988) Leukotriene generation and metabolism in isolated human lung macrophages. Immunology 65: 529–536
  CAS PubMed PubMed Central Google Scholar
• Levy BD et al. (1993) Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 92: 1572–1579
  Article CAS Google Scholar
• Nassar GM et al. (1994) Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 269: 27631–27634
  CAS PubMed Google Scholar
• Profita M et al. (2002) Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase. J Pharmacol Exp Ther 300: 868–875
  Article CAS Google Scholar
• Levy BD et al. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2: 612–619
  Article CAS Google Scholar
• Peters-Golden M et al. (2005) Leukotrienes: underappreciated mediators of innate immune responses. J Immunol 174: 589–594
  Article CAS Google Scholar
• Tager AM et al. (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4: 982–990
  Article CAS Google Scholar
• Prinz I et al. (2005) The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta- and gamma delta effector T cells. J Immunol 175: 713–719
  Article CAS Google Scholar
• Brink C et al. (2003) International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55: 195–227
  Article CAS Google Scholar
• Gronert K et al. (2001) Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am J Pathol 158: 3–9
  Article CAS Google Scholar
• Serhan CN et al. (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171: 6856–6865
  Article CAS Google Scholar
• Mensing H et al. (1984) Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol 82: 9–12
  Article CAS Google Scholar
• Baud L et al. (1987) Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol 138: 1190–1195
  CAS PubMed Google Scholar
• Phan SH et al. (1988) Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry 27: 2846–2853
  Article CAS Google Scholar
• Perng DW et al. (2006) Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol 34: 101–107
  Article CAS Google Scholar
• Peters-Golden M et al. (2002) Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 165: 229–235
  Article Google Scholar
• Beller TC et al. (2004) Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci USA 101: 3047–3052
  Article CAS Google Scholar
• Vargaftig BB et al. (2003) Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol 28: 410–419
  Article CAS Google Scholar
• Kolodsick JE et al. (2004) Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J Immunol 172: 4068–4076
  Article CAS Google Scholar
• Beller TC et al. (2004) Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 279: 46129–46134
  Article CAS Google Scholar
• McMahon B et al. (2002) Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 16: 1817–1819
  Article CAS Google Scholar
• Sato Y et al. (2004) Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo. Biomed Pharmacother 58: 381–387
  Article CAS Google Scholar
• Wu SH et al. (2006) Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am J Respir Cell Mol Biol 34: 65–72
  Article CAS Google Scholar
• Mitchell D et al. (2004) Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am J Pathol 164: 937–946
  Article CAS Google Scholar
• McMahon B et al. (2000) Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J Biol Chem 275: 27566–27575
  CAS PubMed Google Scholar
• Wu SH et al. (2005) Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells. Kidney Int 68: 35–46
  Article CAS Google Scholar
• Wu SH et al. (2005) High dose of lipoxin A4 induces apoptosis in rat renal interstitial fibroblasts. Prostaglandins Leukot Essent Fatty Acids 73: 127–137
  Article CAS Google Scholar
• Rodgers K et al. (2005) Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am J Pathol 167: 683–694
  Article CAS Google Scholar
• Wu SH et al. (2006) Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney Int 69: 248–256
  Article CAS Google Scholar
• Vachier I et al. (2005) Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 115: 55–60
  Article CAS Google Scholar
• Kowal-Bielecka O et al. (2003) Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease. Arthritis Rheum 48: 1639–1646
  Article CAS Google Scholar
• Silver RM et al. (1990) Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 88: 470–476
  Article CAS Google Scholar
• Wilborn J et al. (1996) Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 97: 1827–1836
  Article CAS Google Scholar
• Kowal-Bielecka O et al. (2005) Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis. Ann Rheum Dis 64: 484–486
  Article CAS Google Scholar
• Witt C et al. (1999) Pulmonary involvement in diffuse cutaneous systemic sclerosis: bronchoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis. Ann Rheum Dis 58: 635–640
  Article CAS Google Scholar
• White B et al. (2000) Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 132: 947–954
  Article CAS Google Scholar
• Kowal-Bielecka O et al. (2005) Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations. Ann Rheum Dis 64: 1343–1346
  Article CAS Google Scholar
• Goldstein RA et al. (1990) Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 142: 481–486
  Article CAS Google Scholar
• Kowal-Bielecka O et al. (2001) Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis. Arthritis Rheum 44: 1865–1875
  Article CAS Google Scholar
• Huang L et al. (2004) Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler Thromb Vasc Biol 24: 1783–1788
  Article CAS Google Scholar
• Ichiyama T et al. (2005) Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages. Clin Exp Allergy 35: 1214–1219
  Article CAS Google Scholar
• Meloni F et al. (2004) BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis 21: 111–118
  PubMed Google Scholar
• Distler O et al. (2001) Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum 44: 2665–2678
  Article CAS Google Scholar
• Distler JH et al. (2006) Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Arthritis Rheum 54: 214–225
  Article CAS Google Scholar
• Kowal-Bielecka O et al. (2005) Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis Rheum 52: 3783–3791
  Article CAS Google Scholar
• Flaherty KR et al. (2004) Zileuton versus azathioprine/prednisone in idiopathic pulmonary fibrosis. Europ Respir J 24 (Suppl 48): S254
  Google Scholar
• Petasis NA et al. (2005) Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot Essent Fatty Acids 73: 301–321
  Article CAS Google Scholar
• Tager AM et al. (2003) BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot Essent Fatty Acids 69: 123–134
  Article CAS Google Scholar
• Qiu H et al. (2006) Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc Natl Acad Sci USA 103: 6913–6918
  Article CAS Google Scholar
• Kanaoka Y et al. (2004) Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 173: 1503–1510
  Article CAS Google Scholar
• Uzonyi B et al. (2006) Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Proc Natl Acad Sci USA 103: 6326–6331
  Article CAS Google Scholar